The Alzheimer's drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS
Companies

New Alzheimer’s drug holds promise but adds cost pressures for Medicare

https://bizrepublic.com/